Sana Biotechnology, Inc. (SANA)
NASDAQ·Healthcare·Biotechnology
$3.36
+2.91%
Mkt Cap $918.02M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | — | — | — | -$0.13 | -$0.16 | -23.08% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$0.18 | -$0.15 | +16.67% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.20 | -$0.16 | +20.00% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.22 | -$0.20 | +9.09% | — | — |
| Q1 2025 Mar 17, 2025 | — | — | — | -$0.25 | -$0.23 | +8.00% | — | — |
| Q4 2024 Nov 8, 2024 | — | — | — | -$0.26 | -$0.25 | +3.85% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.27 | -$0.32 | -18.52% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.30 | -$0.32 | -6.67% | — | — |
| Q1 2024 Feb 29, 2024 | — | — | — | -$0.37 | -$0.35 | +5.41% | — | — |
| Q4 2023 Nov 8, 2023 | — | — | — | -$0.42 | -$0.41 | +2.38% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$0.42 | -$0.45 | -7.14% | — | — |
| Q2 2023 May 8, 2023 | — | — | — | -$0.38 | -$0.43 | -13.16% | — | — |
| Q1 2023 Mar 16, 2023 | — | — | — | -$0.41 | -$0.40 | +2.44% | — | — |
| Q4 2022 Nov 2, 2022 | — | — | — | -$0.39 | -$0.48 | -23.08% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$0.46 | -$0.47 | -2.17% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$0.38 | -$0.47 | -23.68% | — | — |
| Q1 2022 Mar 16, 2022 | — | — | — | $0.36 | -$0.65 | -280.56% | — | — |
| Q4 2021 Nov 8, 2021 | — | — | — | -$0.29 | -$0.37 | -27.59% | — | — |
| Q3 2021 Aug 4, 2021 | — | — | — | -$0.37 | -$0.32 | +13.51% | — | — |
| Q2 2021 May 5, 2021 | — | — | — | -$0.35 | -$0.45 | -28.57% | — | — |